Literature DB >> 27272659

[Clinical Evaluation of Proton Therapy - How much benefit can be considered a benefit?].

Stephanie E Combs1,2.   

Abstract

Mesh：

Year:  2016        PMID： 27272659     DOI： 10.1007/s00066-016-0994-8

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  4 in total

Review 1.  An evidence based review of proton beam therapy: the report of ASTRO's emerging technology committee.

Authors:  Aaron M Allen; Todd Pawlicki; Lei Dong; Eugene Fourkal; Mark Buyyounouski; Keith Cengel; John Plastaras; Mary K Bucci; Torunn I Yock; Luisa Bonilla; Robert Price; Eleanor E Harris; Andre A Konski
Journal:  Radiother Oncol       Date:  2012-03-09       Impact factor: 6.280

2.  Outcome and prognostic factors of radiation therapy for medulloblastoma.

Authors:  Stefan Rieken; Angela Mohr; Daniel Habermehl; Thomas Welzel; Katja Lindel; Olaf Witt; Andreas E Kulozik; Wolfgang Wick; Jürgen Debus; Stephanie E Combs
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-02-23       Impact factor: 7.038

3.  Adult medulloblastoma: prognostic factors and patterns of relapse.

Authors:  A W Chan; N J Tarbell; P M Black; D N Louis; M P Frosch; M Ancukiewicz; P Chapman; J S Loeffler
Journal:  Neurosurgery       Date:  2000-09       Impact factor: 4.654

4.  Treatment of pediatric patients and young adults with particle therapy at the Heidelberg Ion Therapy Center (HIT): establishment of workflow and initial clinical data.

Authors:  Stephanie E Combs; Kerstin A Kessel; Klaus Herfarth; Alexandra Jensen; Susanne Oertel; Claudia Blattmann; Swantje Ecker; Angelika Hoess; Eike Martin; Olaf Witt; Oliver Jäkel; Andreas E Kulozik; Jürgen Debus
Journal:  Radiat Oncol       Date:  2012-10-17       Impact factor: 3.481
  4 in total
  2 in total

1.  Medulloblastoma in adults : A retrospective single institution analysis.

Authors:  Indrawati Hadi; Olarn Roengvoraphoj; Maximilian Niyazi; Falk Roeder; Ulrich Schüller; Claus Belka; Silke Birgit Nachbichler
Journal:  Strahlenther Onkol       Date:  2017-11-16       Impact factor: 3.621

2.  Impact of radiation technique, radiation fraction dose, and total cisplatin dose on hearing : Retrospective analysis of 29 medulloblastoma patients.

Authors:  Sergiu Scobioala; Ross Parfitt; Peter Matulat; Christopher Kittel; Fatemeh Ebrahimi; Heidi Wolters; Antoinette Am Zehnhoff-Dinnesen; Hans Theodor Eich
Journal:  Strahlenther Onkol       Date:  2017-09-08       Impact factor: 3.621
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.